First-in-human study to assess safety, tolerability and pharmacokinetics of APX001 administered by intravenous infusion to healthy subjects

Authors
Category Primary study
JournalOpen Forum Infectious Diseases
Year 2017
This article has no abstract
Epistemonikos ID: 892f75ab8e968b3a22168c83537a6a4ad3452ae9
First added on: Feb 10, 2025